Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
Enregistré dans:
Auteurs principaux: | Ann Taber, Emil Christensen, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fb71e221dff14ceab6bffe89d0363cd6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
par: Ann Taber, et autres
Publié: (2020) -
Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
par: Mathieu Roumiguie, et autres
Publié: (2021) -
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
par: Sia Viborg Lindskrog, et autres
Publié: (2021) -
Cisplatin is retained in the cochlea indefinitely following chemotherapy
par: Andrew M. Breglio, et autres
Publié: (2017) -
Reconciling Anti-Essentialism and Quantitative Methodology
par: Mathias Fjællegaard Jensen
Publié: (2017)